Financial incentives to dispense low-cost drugs
| dc.contributor.author | Grootendorst, Paul. | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.contributor.author | British Columbia Pharmacare. | en_US |
| dc.coverage.spatial | British Columbia | en_US |
| dc.coverage.spatial | Ontario | en_US |
| dc.coverage.spatial | British Columbia | en_US |
| dc.coverage.spatial | British Columbia | en_US |
| dc.coverage.spatial | British Columbia | en_US |
| dc.coverage.spatial | British Columbia | en_US |
| dc.date.accessioned | 2015-04-14T14:41:54Z | |
| dc.date.available | 2015-04-14T14:41:54Z | |
| dc.date.issued | 1996 | en_US |
| dc.description | Paul Grootendorst ... [et al.]. | en_US |
| dc.description | Includes bibliographical references (p. 25). | en_US |
| dc.format.extent | 40 p. ; 28 cm. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/16949 | |
| dc.publisher | McMaster University | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 95-8 | en_US |
| dc.subject | Insurance, Pharmaceutical Services | en_US |
| dc.subject | Prescription Drugs | en_US |
| dc.subject | economics | en_US |
| dc.subject | Drug Utilization Review | en_US |
| dc.subject | Economics, Pharmaceutical | en_US |
| dc.subject | Pharmaceutical Services | en_US |
| dc.subject | economics | en_US |
| dc.subject | Therapeutic Equivalency | en_US |
| dc.title | Financial incentives to dispense low-cost drugs | en_US |
| dc.type | text | en_US |